Medication adherence is a mediator of the relationship between ethnicity and event-free survival in patients with heart failure
- PMID: 20142026
- PMCID: PMC2819978
- DOI: 10.1016/j.cardfail.2009.10.017
Medication adherence is a mediator of the relationship between ethnicity and event-free survival in patients with heart failure
Abstract
Background: Rehospitalization rates are higher in African American than Caucasian patients with heart failure (HF). The reasons for the disparity in outcomes between African Americans and Caucasians may relate to differences in medication adherence. To determine whether medication adherence is a mediator of the relationship between ethnicity and event-free survival in patients with HF.
Methods and results: Medication adherence was monitored longitudinally in 135 HF patients using the Medication Event Monitoring System. Events (emergency department visits for HF exacerbation, HF and cardiac rehospitalization, and all-cause mortality) were obtained by interview and hospital data base review. A series of regression models and survival analyses was conducted to determine whether medication adherence mediated the relationship between ethnicity and event-free survival. Event-free survival was significantly worse in African Americans than Caucasians. Ethnicity was a predictor of medication adherence (P=.011). African Americans were 2.57 times more likely to experience an event than Caucasians (P=.026). Ethnicity was not a predictor of event-free survival after entering medication adherence in the model (P=.06).
Conclusions: Medication adherence was a mediator of the relationship between ethnicity and event-free survival in this sample. Interventions designed to reduce barriers to medication adherence may decrease the disparity in outcomes.
Copyright 2010 Elsevier Inc. All rights reserved.
Figures
Comment in
-
Ethnicity and medication adherence: factors that need to be taken into account.J Card Fail. 2010 Jul;16(7):619. doi: 10.1016/j.cardfail.2010.05.001. J Card Fail. 2010. PMID: 20610240 No abstract available.
Similar articles
-
Medication adherence mediates the relationship between marital status and cardiac event-free survival in patients with heart failure.Heart Lung. 2012 Mar-Apr;41(2):107-14. doi: 10.1016/j.hrtlng.2011.09.009. Epub 2011 Nov 3. Heart Lung. 2012. PMID: 22054720 Free PMC article.
-
Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure.J Gen Intern Med. 2014 Apr;29(4):602-7. doi: 10.1007/s11606-013-2692-x. Epub 2013 Dec 24. J Gen Intern Med. 2014. PMID: 24366395 Free PMC article. Clinical Trial.
-
Medication Adherence Mediates the Relationship Between Heart Failure Symptoms and Cardiac Event-Free Survival in Patients With Heart Failure.J Cardiovasc Nurs. 2018 Jan/Feb;33(1):40-46. doi: 10.1097/JCN.0000000000000427. J Cardiovasc Nurs. 2018. PMID: 28591004 Free PMC article.
-
Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials.J Am Heart Assoc. 2016 Jun 17;5(6):e002606. doi: 10.1161/JAHA.115.002606. J Am Heart Assoc. 2016. PMID: 27317347 Free PMC article. Review.
-
Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence.J Clin Hypertens (Greenwich). 2017 Oct;19(10):1015-1024. doi: 10.1111/jch.13089. Epub 2017 Aug 30. J Clin Hypertens (Greenwich). 2017. PMID: 28856834 Free PMC article. Review.
Cited by
-
Cardiovascular risk.Br J Clin Pharmacol. 2012 Sep;74(3):396-410. doi: 10.1111/j.1365-2125.2012.04219.x. Br J Clin Pharmacol. 2012. PMID: 22348281 Free PMC article. Review.
-
The Impact of Race and Neighborhood Racial Composition on Preventable Readmissions for Diabetic Medicare Home Health Beneficiaries.J Racial Ethn Health Disparities. 2017 Aug;4(4):648-658. doi: 10.1007/s40615-016-0268-2. Epub 2016 Aug 11. J Racial Ethn Health Disparities. 2017. PMID: 27514389
-
Feasibility of including patients with migration background in a structured heart failure management programme: A prospective case-control study exemplarily on Turkish migrants.PLoS One. 2017 Nov 8;12(11):e0187358. doi: 10.1371/journal.pone.0187358. eCollection 2017. PLoS One. 2017. PMID: 29117200 Free PMC article.
-
Medication adherence: emerging use of technology.Curr Opin Cardiol. 2011 Jul;26(4):279-87. doi: 10.1097/HCO.0b013e328347c150. Curr Opin Cardiol. 2011. PMID: 21597368 Free PMC article. Review.
-
Psychosocial predictors of health behavior adherence in heart-failure patients with comorbid depression: a secondary analysis of the Hopeful Heart trial.BMC Psychol. 2024 Jun 4;12(1):328. doi: 10.1186/s40359-024-01816-4. BMC Psychol. 2024. PMID: 38835104 Free PMC article. Clinical Trial.
References
-
- Lloyd-Jones D, Adams R, Carnethon M, et al. Heart Disease and Stroke Statistics--2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008 - PubMed
-
- Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–146. - PubMed
-
- Opasich C, Febo O, Riccardi PG, et al. Concomitant factors of decompensation in chronic heart failure. Am. J. Cardiol. 1996;78:354–357. - PubMed
-
- Norgard NB, Stark JE. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers. Pharmacotherapy. 2008;28:920–931. - PubMed
-
- Fonarow GC, Abraham WT, Albert NM, et al. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF. J. Card. Fail. 2007;13:722–731. - PubMed
Publication types
MeSH terms
Grants and funding
- M01 RR000034/RR/NCRR NIH HHS/United States
- M01 RR002602-225137/RR/NCRR NIH HHS/United States
- M01 RR000034-440643/RR/NCRR NIH HHS/United States
- M01 RR000034-380538/RR/NCRR NIH HHS/United States
- R01 NR008567-01A1/NR/NINR NIH HHS/United States
- 1P20NR010679./NR/NINR NIH HHS/United States
- M01 RR002602/RR/NCRR NIH HHS/United States
- P20 NR010679-03/NR/NINR NIH HHS/United States
- M01 RR000034-40S10619/RR/NCRR NIH HHS/United States
- P20 NR010679/NR/NINR NIH HHS/United States
- M01 RR002602-210220/RR/NCRR NIH HHS/United States
- R01 NR008567-02/NR/NINR NIH HHS/United States
- P20 NR010679-01/NR/NINR NIH HHS/United States
- P20 NR010679-02/NR/NINR NIH HHS/United States
- M01 RR000034-390538/RR/NCRR NIH HHS/United States
- M01RR02602/RR/NCRR NIH HHS/United States
- R01 NR008567/NR/NINR NIH HHS/United States
- M01 RR002602-225140/RR/NCRR NIH HHS/United States
- R01 NR008567-05/NR/NINR NIH HHS/United States
- M01 RR000034-370538/RR/NCRR NIH HHS/United States
- M01 RR000034-400619/RR/NCRR NIH HHS/United States
- M01 RR000034-420538/RR/NCRR NIH HHS/United States
- M01 RR002602-22S15356/RR/NCRR NIH HHS/United States
- M01 RR002602-210211/RR/NCRR NIH HHS/United States
- R01 NR008567-04/NR/NINR NIH HHS/United States
- M01 RR002602-200220/RR/NCRR NIH HHS/United States
- M01 RR002602-200211/RR/NCRR NIH HHS/United States
- M01 RR002602-22S15353/RR/NCRR NIH HHS/United States
- M01 RR000034-410538/RR/NCRR NIH HHS/United States
- R01 NR008567-03/NR/NINR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous